Skip to content

Frontlight Research

Trial site

Concord

Concord, AustraliaNot linked to an institution yet

1running trials
3closed trials
0trials confirmed by the site in the last 60 days
–languages not stated

The site has not confirmed any trial yet.

Running trials

Active, not recruiting
A Long-term Extension Study of PCI-32765 (Ibrutinib)
NCT01804686· PHASE3· Source

Researchers

No researcher is linked here yet.

Closed trials

Completed
A Study to Evaluate 3 Dose Schedules of Daratumumab in Participants With Smoldering Multiple Myeloma
NCT02316106· PHASE2· Source
Completed
Addition of Daratumumab to Combination of Bortezomib and Dexamethasone in Participants With Relapsed or Refractory Multiple Myeloma
NCT02136134· PHASE3· Source
Completed
A Study of the Bruton's Tyrosine Kinase Inhibitor Ibrutinib Given in Combination With Bendamustine and Rituximab in Patients With Newly Diagnosed Mantle Cell Lymphoma
NCT01776840· PHASE3· Source

Site data: CTGOVUpdated 5 Nov 2026

Report an error